Merit Medical Systems (MMSI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
31 Mar, 2026Executive summary
Annual meeting scheduled for May 13, 2026, at 2:00 p.m. Mountain Time, to be held virtually.
Shareholders are encouraged to review proxy materials and vote by May 12, 2026, or May 8, 2026, for 401(k) plan shares.
Voting matters and shareholder proposals
Election of four directors: Martha G. Aronson (3-year term), Lonny J. Carpenter (3-year term), Lynne N. Ward (1-year term), Scott R. Ward (3-year term).
Advisory vote on executive compensation (say-on-pay) for named executive officers.
Approval of the 2026 Equity Incentive Plan.
Approval of the 2026 Employee Stock Purchase Plan.
Ratification of Deloitte & Touche LLP as independent auditor for the year ending December 31, 2026.
Proxies may vote on other business arising at the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and proposals.
Director terms vary, with three nominees for three-year terms and one for a one-year term.
Latest events from Merit Medical Systems
- Strategic changes and strong execution drive growth and margin expansion amid a smooth CEO transition.MMSI
Goldman Sachs 47th Annual Global Healthcare Conference 20268 Jun 2026 - Platform-based strategy, targeted innovation, and disciplined M&A drive diversified growth.MMSI
Bank of America Global Healthcare Conference 202618 May 2026 - All proposals passed, new leadership welcomed, and record financial results highlighted.MMSI
AGM 202613 May 2026 - Q1 2026 saw robust growth, oncology expansion, and raised guidance after a major acquisition.MMSI
Q1 20261 May 2026 - Double-digit 2025 growth and strong 2026 outlook, despite tariff and divestiture risks.MMSI
Q4 20259 Apr 2026 - Shareholders to vote on directors, pay, equity plans, and auditor amid record results and a CEO transition.MMSI
Proxy filing31 Mar 2026 - Strong 2025 growth, new leadership, and innovation drive global expansion and margin gains.MMSI
44th Annual J.P. Morgan Healthcare Conference24 Feb 2026 - Q2 2024 revenue and profit exceeded expectations, prompting raised full-year guidance.MMSI
Q2 20242 Feb 2026 - Raised guidance, strong cash flow, and strategic M&A drive growth and innovation.MMSI
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026